Gonçalves, L.; Guedes, H.; Fortuna, A.R.; Lemos, T.; Gramaça, J.; Mourão, N.; Cunha, G.; Pichel, R.; Simões, P.; LuÃs, J.A.;
et al. Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing. Cancers 2025, 17, 898.
https://doi.org/10.3390/cancers17050898
AMA Style
Gonçalves L, Guedes H, Fortuna AR, Lemos T, Gramaça J, Mourão N, Cunha G, Pichel R, Simões P, LuÃs JA,
et al. Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing. Cancers. 2025; 17(5):898.
https://doi.org/10.3390/cancers17050898
Chicago/Turabian Style
Gonçalves, Lisa, Helena Guedes, Ana Raquel Fortuna, Tânia Lemos, João Gramaça, Natacha Mourão, Gonçalo Cunha, Rita Pichel, Pedro Simões, Joana Alves LuÃs,
and et al. 2025. "Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing" Cancers 17, no. 5: 898.
https://doi.org/10.3390/cancers17050898
APA Style
Gonçalves, L., Guedes, H., Fortuna, A. R., Lemos, T., Gramaça, J., Mourão, N., Cunha, G., Pichel, R., Simões, P., LuÃs, J. A., Freitas, R., Dunões, I., Spencer, A. S., Marinho, J., & Costa, L.
(2025). Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing. Cancers, 17(5), 898.
https://doi.org/10.3390/cancers17050898
